Edgen Stock·Sep 20 2025, 17:40戻る
戻る
Merck Navigates Patent Expiry with New Drug Pipeline as Keytruda Approaches 2028 LOE
Edgen Stock·Sep 20 2025, 17:40
[1] Can MRK's New Drugs Drive Long-Term Growth Amid Looming Keytruda LOE? (https://finance.yahoo.com/news/mrks-drugs-dri ...)[2] Merck's Keytruda Injectable Version: A Paradigm Shift in Oncology Access and Profitability? (https://vertexaisearch.cloud.google.com/groun ...)[3] Can MRK's New Drugs Drive Long-Term Growth Amid Looming Keytruda LOE? - Nasdaq (https://vertexaisearch.cloud.google.com/groun ...)